Ali, A. M., Radtke, K. K., Hesseling, A. C., Winckler, J., Schaaf, H. S., Draper, H. R., . . . Savic, R. M. (2023). QT Interval Prolongation with One or More QT-Prolonging Agents Used as Part of a Multidrug Regimen for Rifampicin-Resistant Tuberculosis Treatment: Findings from Two Pediatric Studies. Antimicrobial agents and chemotherapy, 67(7), e0144822. https://doi.org/10.1128/aac.01448-22
Chicago-Zitierstil (17. Ausg.)Ali, Ali Mohamed, et al. "QT Interval Prolongation with One or More QT-Prolonging Agents Used as Part of a Multidrug Regimen for Rifampicin-Resistant Tuberculosis Treatment: Findings from Two Pediatric Studies." Antimicrobial Agents and Chemotherapy 67, no. 7 (2023): e0144822. https://doi.org/10.1128/aac.01448-22.
MLA-Zitierstil (9. Ausg.)Ali, Ali Mohamed, et al. "QT Interval Prolongation with One or More QT-Prolonging Agents Used as Part of a Multidrug Regimen for Rifampicin-Resistant Tuberculosis Treatment: Findings from Two Pediatric Studies." Antimicrobial Agents and Chemotherapy, vol. 67, no. 7, 2023, p. e0144822, https://doi.org/10.1128/aac.01448-22.